1,2-Dichloroethane → methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]amino]-4-phenylbutyl]-2-[[4-(1,3-thiazol-2-yl)phenyl]methyl]hydrazinyl]-3-methyl-1-oxobutan-2-yl]carbamate

HRID 1276985Notes

Reaction equation

HRID 1276985 reaction equation
[CH3:1][O:2][C:3]([NH:5][C@H:6]([C:10](O)=[O:11])[CH:7]([CH3:9])[CH3:8])=[O:4].C(Cl)CCl.C1C=CC2N(O)N=NC=2C=1.[S:27]1[CH:31]=[CH:30][N:29]=[C:28]1[C:32]1[CH:37]=[CH:36][C:35]([CH2:38][N:39]([NH2:63])[CH2:40][C@H:41]([OH:62])[C@@H:42]([NH:50][C:51](=[O:61])[C@H:52]([CH:58]([CH3:60])[CH3:59])[NH:53][C:54]([O:56][CH3:57])=[O:55])[CH2:43][C:44]2[CH:49]=[CH:48][CH:47]=[CH:46][CH:45]=2)=[CH:34][CH:33]=1>CN(C=O)C>[CH3:59][CH:58]([C@H:52]([NH:53][C:54]([O:56][CH3:57])=[O:55])[C:51]([NH:50][C@H:42]([C@@H:41]([OH:62])[CH2:40][N:39]([NH:63][C:10]([C@@H:6]([NH:5][C:3]([O:2][CH3:1])=[O:4])[CH:7]([CH3:9])[CH3:8])=[O:11])[CH2:38][C:35]1[CH:34]=[CH:33][C:32]([C:28]2[S:27][CH:31]=[CH:30][N:29]=2)=[CH:37][CH:36]=1)[CH2:43][C:44]1[CH:49]=[CH:48][CH:47]=[CH:46][CH:45]=1)=[O:61])[CH3:60]

Participants

6

Procedure

Analogously to Example 7,140 mg (0.80 mmol) of N-methoxycarbonyl-(L)-valine, 288 mg (1.5 mmol) of EDC and 135 mg (1.0 mmol) of HOBT in 2.2 ml of DMF and 418 μl (3.0 mmol) of TEA are reacted with 0.5 mmol of 1-[4-(thiazol-2-yl)-phenyl]-4(S)-hydroxy-2-amino-5(S)-N-(N-methoxycarbonyl-(L)-valyl)amino-6-phenyl-2-azahexane in 4.5 ml of DMF to form the title compound: m.p: 207-210° C.; HPLC20-100 : tRet =13.8; FAB MS (M+H)+ =683.

Sources & evidence

ORD record
ord-c29ce6871ba94d7095a6511850c71b86
Source dataset
uspto-grants-2000_12
Patent number
US06166004

Reaction notes

Loading…